Compared to the low-grade prostate cancer cell lines (LNCaP and C4-2), the SLC12A5 expression levels were remarkably higher in the high-grade prostate cancer cell lines (22RV-1, DU145 and PC3) (Supplementary Fig. S1E). This evidence concerns the gene SLC12A5 and prostate carcinoma.